دورية أكاديمية

[Overexpression and its clinical significance of multi-drug resistance associated genes in lung cancer tissues].

التفاصيل البيبلوغرافية
العنوان: [Overexpression and its clinical significance of multi-drug resistance associated genes in lung cancer tissues].
المؤلفون: Li G; Department of Chest Surgery, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222002, P.R.China., Dai J, Wang Y, Chen G, Liu X, Miao F, Bai L, Chen Y
المصدر: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2002 Feb 20; Vol. 5 (1), pp. 35-7.
نوع المنشور: English Abstract; Journal Article
اللغة: Chinese
بيانات الدورية: Publisher: Zhongguo fei ai za zhi bian ji wei yuan hui Country of Publication: China NLM ID: 101126433 Publication Model: Print Cited Medium: Print ISSN: 1009-3419 (Print) Linking ISSN: 10093419 NLM ISO Abbreviation: Zhongguo Fei Ai Za Zhi Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2008- : Tianjin Shi : Zhongguo fei ai za zhi bian ji wei yuan hui
Original Publication: Chendu Shi : Zhongguo fei ai za zhi bian ji wei yuan hui
مستخلص: Background: To investigate the expression level and its clinical significance of the multi-drug resistance (MDR) associated protein in lung cancer specimens.
Methods: The expression levels of Pgp, MRP, GST-π and TopoII of MDR associated protein were detected in 60 lung cancer samples and 30 paracancerous tissues by S-P immunohistochemistry method.
Results: The positive rate of Pgp, MRP, GST-π and Topo II in the lung cancer tissues was 40.0% (24/60), 61.7% (37/60), 45.0% (27/60) and 81.7% (49/60) respectively, which was significantly higher than those in paracancerous tissues (P < 0.01). No significant correlation was observed among the expression of multi-drug resistance-related protein and TNM staging, pathological type, cell differention and lymph node metastasis status (P > 0.05).
Conclusions: Lung cancer has overexpression of multi-drug resistant-related genes during the oncogenesis. Combined detection of these genes may be useful for guiding the lung cancer chemotherapy.
تواريخ الأحداث: Date Created: 20110215 Date Completed: 20121002 Latest Revision: 20110214
رمز التحديث: 20221213
DOI: 10.3779/j.issn.1009-3419.2002.01.10
PMID: 21315026
قاعدة البيانات: MEDLINE
الوصف
تدمد:1009-3419
DOI:10.3779/j.issn.1009-3419.2002.01.10